H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 8.9% of adults in Portland have diagnosed diabetes — 3.1 points below the U.S. 12% figure. Census population 652,503. Oregon Medicare wound biologics: Noridian Healthcare Solutions (JF). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Portland clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Portland storefront.
Growth Factor Therapy for Tissue Repair in Portland, OR for clinics & physicians. Growth factor therapy pr… Compliance support & pricing — contact Hawk Medical.
Adult arthritis here is 21.2% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. CDC PLACES (2023, crude) estimates 8.9% of adults in Portland have diagnosed diabetes — 3.1 points below the U.S. 12% figure. Together those PLACES numbers are why a city of 500k–1M still needs separate PRP and CTP protocols. growth factor therapy inventory is national; utilization is JF-local.
National Growth Factor Therapy for Tissue Repair notes (how the product actually works)America’s Health Rankings (BRFSS 2024) only publishes state diabetes as a range nationally (Colorado 8.4% to West Virginia 18.4%). For Portland we use CDC PLACES instead of interpolating a fake city rate from that range. CDC PLACES (2023, crude) estimates 8.9% of adults in Portland have diagnosed diabetes — 3.1 points below the U.S. 12% figure.
If you already buy growth factor therapy elsewhere, use this page as a check: homologous-use language, current Noridian Healthcare Solutions article IDs, and PLACES 8.9% diabetes as the epidemiologic floor. If that is how you already practice, the catalog will fit.
CDC PLACES (2023, crude prevalence) estimates 8.9% of adults — 3.1 points below the U.S. 12% figure. Obesity is 28.5%; arthritis is 21.2%. That is place-level BRFSS modeling, not a clinic census and not a Portland trial.
Use the contact form or book a 15-minute call with Joe Bradley. Bring specialty, monthly wound or joint volume, and whether you bill JF FFS, Advantage, workers’ comp, or cash-pay.
Often yes, which is the point of vendor consolidation. Keep DME delivery tickets and HCT/P lot files separate so a Oregon audit trail stays clean.
It is the Census city-proper count — useful as scale for a city of 500k–1M. It is not a count of orthopedic groups, wound centers, or competitors. Underwrite the program against your referral sources, not against the skyline.
If you operate in Oregon and another MAC state, say it on the first call. JF will not port 1:1. We would rather split utilization than watch a sister clinic copy Portland tickets into the wrong jurisdiction.
Contact us to learn how Hawk Medical supports practices in Portland, OR.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Portland is JF geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Portland — 3.1 points below the U.S. 12% figure. Planning input, not an outcomes claim.
Oregon Part B wound biologics follow this contractor (siblings: AK, AZ, ID, MT, ND, SD, UT, WA, WY). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Portland. Useful for joint-program math; still needs a diagnosis and privileging.
No Portland storefront. Joe Bradley is an active practice owner. growth factor therapy stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.